SWOG S2206

Primary Category:

Treatment Protocols

Disease Category:

Breast, Breast Neoadjuvant

Status:

New, Open

Phase III Trial of Neoadjuvant Durvalumab (NSC 778709) Plus Chemotherapy Versus Chemotherapy Alone for Adults with MammaPrint Ultrahigh (MP2) Hormone Receptor (HR) Positive / Human Epidermal Growth Factor Receptor (HER2) Negative Stage II-III Breast Cancer

NCT#06058377